umbralisib (Ukoniq) Report issue

Small molecule Orphan Drug FDA Approved FDA Breakthrough Therapy FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL PubChem

Back

Chemistry

Mol. Mass

571.56

ALogP

6.66

Rule of 5

No

Rule of 3

No
Details
  • SMILES: CC(C)Oc1ccc(cc1F)c2nn([C@@H](C)C3=C(C(=O)c4cc(F)ccc4O3)c5cccc(F)c5)c6ncnc(N)c26
  • InChIKey: IUVCFHHAEHNCFT-INIZCTEOSA-N
    InChI=1S/C31H24F3N5O3/c1-15(2)41-24-9-7-18(12-22(24)34)27-26-30(35)36-14-37-31(26)39(38-27)16(3)29-25(17-5-4-6-19(32)11-17)28(40)21-13-20(33)8-10-23(21)42-29/h4-16H,1-3H3,(H2,35,36,37)/t16-/m0/s1
  • Chirality: Single Stereoisomer
  • Inorganic: No
  • Polymer: No

Sources

CHEMBL3948730   ChEMBL
umbralisib *

CHEMBL3545267   ChEMBL

CHEMBL3989869   ChEMBL
umbralisib tosylate

Umbralisib   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue